Rapid reduction of hard exudates in eyes with diabetic retinopathy after intravitreal triamcinolone: data from a randomized, placebo‐controlled, clinical trial
Authors:
Open Access
- 17 April 2009
- journal article
- research article
- Published by Wiley in Acta Ophthalmologica
- Vol. 87 (3) , 275-280
Abstract
: Purpose: To assess the effect of triamcinolone acetonide over 3 months on hard exudates in patients with diabetic macular oedema (DMO).Methods: Thirty‐two eyes of 16 patients with DMO and hard exudates were included in a randomized, placebo‐controlled trial. Treated eyes received a single‐dose (4 mg) intravitreal injection of triamcinolone acetonide. Control eyes received an injection of subconjunctival saline.Results: The overall area of hard exudates decreased significantly between the baseline and 3‐month visits in treated eyes, but not in control eyes. The mean change in level of hard exudates between the two visits was − 0.75 arbitrary units (AU) (95% confidence interval [CI] − 1.32 to − 0.18) in the central plus inner circle (1500 μm) and − 0.81 AU (95% CI − 1.49 to − 0.13) over the whole grid (3000 μm) in treated eyes, compared with 0.31 AU (95% CI − 0.19 to 0.82) and 0.31 AU (95% CI − 0.11 to 0.74), respectively, in control eyes (p < 0.001). Mean visual acuity improved by five letters in treated but not in control eyes (p = 0.01).Conclusions: Intravitreal triamcinolone reduces hard exudates in the short‐term in eyes with DMO.Keywords
This publication has 28 references indexed in Scilit:
- Management of Diabetic RetinopathyJAMA, 2007
- Intravitreal Triamcinolone for Refractory Diabetic Macular EdemaTwo-Year Results of a Double-Masked, Placebo-Controlled, Randomized Clinical TrialOphthalmology, 2006
- Intravitreal triamcinolone for diabetic macular edema that persists after laser treatmentThree-monthefficacy and safety results of a prospective, randomized, double-masked, placebo-controlled clinical trialOphthalmology, 2004
- Intravitreal triamcinolone for the treatment of refractory diabetic macular oedema with hard exudates: an optical coherence tomography studyBritish Journal of Ophthalmology, 2004
- Intravitreal triamcinolone acetonide for diabetic diffuse macular edema11The authors have no proprietary interest in this study. 22Dr Audren, co–first author, contributed equally to the work.Ophthalmology, 2004
- Histopathology and regression of retinal hard exudates in diabetic retinopathy after reduction of elevated serum lipid levelsOphthalmology, 2003
- Intravitreale Injektion von kristallinem Triamcinolon Acetonid als Therapie des diffusen diabetischen MakulaödemsKlinische Monatsblätter für Augenheilkunde, 2002
- Photocoagulation of diabetic macular oedema; complications and visual outcomeActa Ophthalmologica Scandinavica, 2000
- New surgical approach for removing massive foveal hard exudates in diabetic macular edemaOphthalmology, 1999
- Extravascular Lesions of Diabetic RetinopathyArchives of Ophthalmology (1950), 1962